HC Wainwright & Co. Initiates Coverage On LifeMD with Buy Rating, Announces Price Target of $9
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has initiated coverage on LifeMD (NASDAQ:LFMD) with a Buy rating and a price target of $9.
July 03, 2023 | 11:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LifeMD has been given a Buy rating by HC Wainwright & Co. with a price target of $9.
The Buy rating and price target set by HC Wainwright & Co. indicates a positive outlook for LifeMD. This could potentially attract investors, driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100